H
Hadwiga Nowotny
Researcher at University of Vienna
Publications - 12
Citations - 662
Hadwiga Nowotny is an academic researcher from University of Vienna. The author has contributed to research in topics: Cytogenetics & Myelodysplastic syndromes. The author has an hindex of 7, co-authored 12 publications receiving 654 citations.
Papers
More filters
Journal Article
Multiple Myeloma: High Incidence of Chromosomal Aneuploidy as Detected by Interphase Fluorescence in Situ Hybridization
Johannes Drach,Judith Schuster,Hadwiga Nowotny,Jutta Angerler,Friederike Rosenthal,Michael Fiegl,Christian Rothermundt,Andrea Gsur,Ulrich Jäger,Renate Heinz,Klaus Lechner,Heinz Ludwig,Heinz Huber +12 more
TL;DR: Interphase FISH, by which chromosomal aneuploidy was detected in almost 90% of patients with MM, represents an approach for evaluating the clinical significance of specific chromosomal abnormalities in MM.
Journal ArticleDOI
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.
Thomas Nösslinger,Regina Reisner,Elisabeth Koller,Helga Grüner,Heinz Tüchler,Hadwiga Nowotny,E. Pittermann,Michael Pfeilstöcker +7 more
TL;DR: These data cannot provide evidence for the new WHO proposal for myelodysplastic syndromes classification and should not be adopted for routine clinical use at present, but can provide a starting point for further studies involving refined cytogenetics and clinical results.
Journal ArticleDOI
Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics
Michael Pfeilstöcker,Regina Reisner,Thomas Nösslinger,Helga Grüner,Hadwiga Nowotny,Heinz Tüchler,Ernst Schlögl,E. Pittermann,Renate Heinz +8 more
TL;DR: Cytogenetic scores significantly improved the prognostic value of the best clinical/morphological score in regard to both overall survival and preleukaemic duration, and further stress the importance of cytogenetics for predicting prognosis in MDS.
Journal ArticleDOI
Clinicopathogenetic Significance of Chromosomal Abnormalities in Patients With Blastic Peripheral B-Cell Lymphoma
Brigitte Schlegelberger,Thomas Zwingers,Lana Harder,Hadwiga Nowotny,Reiner Siebert,Michael Vesely,Heinrich Bartels,Ruth Sonnen,Georg Hopfinger,Alexander Nader,German Ott,Konrad Müller-Hermelink,Alfred C. Feller,Renate Heinz +13 more
TL;DR: The findings underline that Burkitt's, cb, ib, and blastoid mantle-cell lymphoma are biologically distinct and clinically relevant entities and that cytogenetic findings can be helpful to subtype BBCL.
Journal ArticleDOI
Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML.
Christine Marosi,Ursula Köller,Elisabeth Koller-Weber,Ilse Schwarzinger,Barbara Schneider,Ulrich Jäger,Peter Vahls,Hadwiga Nowotny,Hendrati Pirc-Danoewinata,Günther G. Steger,Gerhard Kreiner,Brunhilde Wagner,Klaus Lechner,Dieter Lutz,Peter Bettelheim,Oskar A. Haas +15 more
TL;DR: The expected correlations of rather immature myeloid immunologic phenotypes with M1 and M2 morphology and CD14 expression in monoblastic leukemias was found and remission rate and survival were significantly worse in 19 patients with complex nonrandom aberrations, where blast cell expression of blood group H antigen and of TdT were significantly increased.